DNA Damage/DNA Repair
The DNA in a human cell receives tens of thousands of damages per day due to both external (exogenous) and internal (endogenous) stress. The exogenous damages are caused by chemical contamination, UV light, ionizing radiation and alkylation/methylation etc, while the endogenous damages are coming from oxidation, alkylation and hydrolysis of bases etc. Since single strand and double strand breaks of DNA will occur after the damage, unrepaired DNA damage leads to cell senescent, apoptosis and malignancies etc. To overcome this threat, cell has developed DNA damage response, to detect DNA damage and mediate its repair.
DNA repair involves multiple mechanisms such as mismatch, base excision, and nucleotide excision repair etc. A group of proteins and pathways are participated in those processes. ATM/ATR kinases and DNA-PK are crucial for the detection of the DNA damage. Chromatin remodelers regulate chromatin accessibility for the DNA repair factors to function. RPA, Rad51 and the fanconi anemia proteins act directly on repairing the DNA damage. p53 network, the RAS GTPase superfamily, and the ubiquitin system also play important part in the DNA damage response. Aberrant DNA damage response is linked to aging, cancer and immune diseases.
-
A3355 Deferasirox Fe3+ chelateSummary: Oral iron chelator
-
A3372 DOXO-EMCHSummary: Prodrug of doxorubicin
-
A3434 Genz-644282Summary: Non-camptothecin inhibitor of topoisomerase I
-
A3872 TH-302Summary: Hypoxia-activated prodrug,inhibits H460/HT29 cell growth
-
A3924 VoreloxinSummary: Topo II inhibitor
-
A3925 Voreloxin HydrochlorideSummary: Antineoplastic naphthyridine analogue
-
A3123 4'-DemethylepipodophyllotoxinSummary: Anti-cancer drug
-
B2296 Topotecan HClSummary: Topoisomerase 1 inhibitor
-
B2293 Irinotecan HCl TrihydrateTarget: TopoisomerasesSummary: Topoisomerase 1 inhibitor
-
B2292 FlumequineSummary: DNA topoisomerase II inhibitor,synthetic chemotherapeutic antibiotic